Schedule 13G ownership disclosure

CURE PHARMA HOLDING CORP COM

Security class unavailable · CUSIP: 23127P104

Event date: 2016-11-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001477932-18-006022
Form type
SC 13G
Filer
Climate Change Investigation, Innovation & Investment Compan
CIK
CIK 1759122
Filed
Dec 17, 2018
Reporting period
Nov 07, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub